多阅片者研究:超快速乳腺磁共振成像用于乳腺癌筛查的诊断准确性
本研究前瞻性收集954名终生风险超过20%女性的1791次筛查检查,7名乳腺放射科医生分别用完整多参数诊断MRI方案与仅超快速乳腺MRI方案阅片201例。仅超快速方案筛查特异度更高(0.82 vs 0.76,P=0.002),敏感度与AUC无显著差异,阅片时间缩短22.8%,阅片者间一致性更优。
要点
- 仅超快速乳腺MRI筛查的敏感度与AUC不劣于完整多参数方案,特异度更高。
- 超快速方案阅片时间比完整方案快22.8%,阅片者间一致性κ=0.730优于0.665。
- 筛查对象为终生乳腺癌风险超过20%的女性,采用3 T设备并交错采集超快速序列。
核心结论
- 仅使用超快速乳腺MRI方案进行筛查不劣于完整多参数诊断MRI方案,且可能带来显著更高的筛查特异度和更短的阅片时间。
研究设计与样本
- 前瞻性多阅片者研究,2012年1月至2014年6月连续收集954名终生风险超过20%女性的1791次筛查检查,采用3 T设备交错采集超快速乳腺MRI与完整多参数诊断MRI(含标准动态增强序列、扩散加权成像和T2加权成像)。
诊断标准与关键数值
- 完整多参数诊断MRI方案 vs 仅超快速乳腺MRI方案:敏感度0.86(95%CI 0.81-0.90)vs 0.84(95%CI 0.78-0.88),P=0.50。
- 完整多参数诊断MRI方案 vs 仅超快速乳腺MRI方案:特异度0.76(95%CI 0.74-0.79)vs 0.82(95%CI 0.79-0.84),P=0.002。
- 完整多参数诊断MRI方案 vs 仅超快速乳腺MRI方案:阳性预测值0.40(95%CI 0.36-0.45)vs 0.45(95%CI 0.41-0.50),P=0.14。
- 完整多参数诊断MRI方案 vs 仅超快速乳腺MRI方案:受试者工作特征曲线下面积0.89(95%CI 0.82-0.96)vs 0.89(95%CI 0.82-0.96),P=0.83。
- 阅片者间一致性:仅超快速乳腺MRI方案κ=0.730(95%CI 0.699-0.761),优于完整多参数诊断MRI方案κ=0.665(95%CI 0.633-0.696)。
临床应用与阅片要点
- 作者结论认为仅超快速乳腺MRI方案筛查不劣于完整多参数诊断MRI方案,可能带来显著更高的筛查特异度和更短的阅片时间。
- 仅超快速乳腺MRI方案阅片比完整多参数诊断MRI方案快22.8%(P<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Breast cancer screening using magnetic resonance imaging (MRI) has limited accessibility due to high costs of breast MRI. Ultrafast dynamic contrast-enhanced breast MRI can be acquired within 2 minutes. We aimed to assess whether screening performance of breast radiologist using an ultrafast breast MRI-only screening protocol is as good as performance using a full multiparametric diagnostic MRI protocol (FDP).
MATERIALS AND METHODS: The institutional review board approved this study, and waived the need for informed consent. Between January 2012 and June 2014, 1791 consecutive breast cancer screening examinations from 954 women with a lifetime risk of more than 20% were prospectively collected. All women were scanned using a 3 T protocol interleaving ultrafast breast MRI acquisitions in a full multiparametric diagnostic MRI protocol consisting of standard dynamic contrast-enhanced sequences, diffusion-weighted imaging, and T2-weighted imaging. Subsequently, a case set was created including all biopsied screen-detected lesions in this period (31 malignant and 54 benign) and 116 randomly selected normal cases with more than 2 years of follow-up. Prior examinations were included when available. Seven dedicated breast radiologists read all 201 examinations and 153 available priors once using the FDP and once using ultrafast breast MRI only in 2 counterbalanced and crossed-over reading sessions.
RESULTS: For reading the FDP versus ultrafast breast MRI alone, sensitivity was 0.86 (95% confidence interval [CI], 0.81-0.90) versus 0.84 (95% CI, 0.78-0.88) (P = 0.50), specificity was 0.76 (95% CI, 0.74-0.79) versus 0.82 (95% CI, 0.79-0.84) (P = 0.002), positive predictive value was 0.40 (95% CI, 0.36-0.45) versus 0.45 (95% CI, 0.41-0.50) (P = 0.14), and area under the receiver operating characteristics curve was 0.89 (95% CI, 0.82-0.96) versus 0.89 (95% CI, 0.82-0.96) (P = 0.83). Ultrafast breast MRI reading was 22.8% faster than reading FDP (P < 0.001). Interreader agreement is significantly better for ultrafast breast MRI (κ = 0.730; 95% CI, 0.699-0.761) than for the FDP (κ = 0.665; 95% CI, 0.633-0.696).
CONCLUSIONS: Breast MRI screening using only an ultrafast breast MRI protocol is noninferior to screening with an FDP and may result in significantly higher screening specificity and shorter reading time.
引用
- van Zelst JCM, Vreemann S, Witt HJ, et al. Multireader Study on the Diagnostic Accuracy of Ultrafast Breast Magnetic Resonance Imaging for Breast Cancer Screening. Invest Radiol. 2018. PMID: 29944483. doi:10.1097/RLI.0000000000000494
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。